Concord Medical Services Holdings Limited (NYSE:CCM – Get Free Report) was the target of a large decline in short interest in October. As of October 30th, there was short interest totaling 2,167 shares, a decline of 68.2% from the October 15th total of 6,821 shares. Approximately 0.1% of the shares of the stock are short sold. Based on an average trading volume of 18,605 shares, the days-to-cover ratio is presently 0.1 days.
Analysts Set New Price Targets
A number of equities analysts have commented on CCM shares. Wall Street Zen raised Concord Medical Services to a “hold” rating in a research note on Saturday, August 15th. Weiss Ratings restated a “sell (e+)” rating on shares of Concord Medical Services in a report on Friday, August 21st. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat, the company currently has a consensus rating of “Sell”.
Read Our Latest Stock Analysis on CCM
Concord Medical Services Price Performance
Shares of CCM traded down $0.04 during mid-day trading on Friday, hitting $3.51. 4,457 shares of the company traded hands, compared to its average volume of 34,086. Concord Medical Services has a one year low of $2.79 and a one year high of $6.80. The business has a 50-day moving average of $3.68 and a 200 day moving average of $4.16.
About Concord Medical Services
Concord Medical Services Holdings Limited was a China-based healthcare services company focused primarily on cancer treatment and diagnostic imaging. The company operated and managed medical facilities that provided radiotherapy, diagnostic imaging, and related oncology services, often through partnerships with hospitals and other healthcare institutions. Its business also included the provision of medical equipment, technology, and management services to healthcare providers. Concord Medical’s facilities and partnerships were concentrated in China, with a focus on expanding access to specialized cancer diagnosis and treatment in major cities and regional medical centers.
See Also
- Five stocks we like better than Concord Medical Services
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.
